Relay Therapeutics (RLAY) Receives Buy Rating from Leerink Partners with $12.00 Price Target

Relay Therapeutics (RLAY) has received a Buy rating and $12.00 price target from Leerink Partners analyst Andrew Berens. This follows a Buy rating from Barclays's Peter Lawson. However, TR | OpenAI reiterated a Hold rating on RLAY. Corporate insider sentiment is negative with an increase in insiders selling their shares. RLAY's market cap is $560.3M and P/E ratio is -1.67.

Relay Therapeutics (RLAY) has seen mixed analyst ratings and a shift in insider sentiment, which may influence its stock price. The company has received a Buy rating and a $12.00 price target from Leerink Partners analyst Andrew Berens, following a similar Buy rating from Barclays' Peter Lawson [1]. However, TR | OpenAI reiterated a Hold rating on RLAY [2]. Additionally, corporate insider sentiment has turned negative, with an increase in insiders selling their shares.

The company's market capitalization stands at $560.3M, with a P/E ratio of -1.67, indicating a challenging valuation. The mixed analyst ratings suggest a cautious approach from some investors, while the negative insider sentiment may also be a red flag. Despite these factors, the company's strong performance in the past year, as it has outperformed its overall industry, may attract long-term investors.

In the current month, RLAY has received 9 Buy Ratings, 10 Hold Ratings, and 0 Sell Ratings, with an average analyst price target of $11.38 [3]. The company's next quarterly earnings estimate is -$0.43, with a range of -$0.51 to -$0.32 [4]. The previous quarter's EPS was -$0.41, and RLAY beat its EPS estimate 100.00% of the time in the past 12 months [4]. The sales forecast for the next quarter is $160.00K, with a range of $0.00 to $680.00K [4].

Given these factors, investors should closely monitor RLAY's financial performance and analyst ratings to make informed decisions.

References:
[1] https://www.tipranks.com/stocks/rlay/forecast
[2] https://www.tipranks.com/stocks/rlay/forecast
[3] https://www.tipranks.com/stocks/rlay/forecast
[4] https://www.tipranks.com/stocks/rlay/forecast